Vulnerable Covid patients to be given GSK's antibody drug on the NHS 'that can fight Omicron' - 1br

Xevudy, made by British pharmaceutical giant GlaxoSmithKline, was shown to slash the risk of hospitalisation and death by 79 per cent in clinical trials.

VIEW MORE : https://bit.ly/1breakingnews